ZA986904B - Process - Google Patents

Process

Info

Publication number: ZA986904B
Authority: ZA; South Africa
Prior art keywords: füä1; ethylü; dibenzoäb; hydroxyethoxy; piperazinyl
Prior art date: 1997-08-01

Application number

ZA986904A

Other languages

English (en)

Inventor

Evan William Snape

Original Assignee

Zeneca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-01

Filing date

1998-07-31

Publication date

1999-02-01

1998-07-31 Application filed by Zeneca Ltd filed Critical Zeneca Ltd

1999-02-01 Publication of ZA986904B publication Critical patent/ZA986904B/xx

Links

XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract 3
BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 abstract 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 1
NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 abstract 1
UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 abstract 1
208000028017 Psychotic disease Diseases 0.000 abstract 1
239000003849 aromatic solvent Substances 0.000 abstract 1
239000002178 crystalline material Substances 0.000 abstract 1
GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 abstract 1
FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 abstract 1
OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 abstract 1
229940043265 methyl isobutyl ketone Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D281/16—[b, f]-condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Neurosurgery (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Psychiatry (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Glass Compositions (AREA)
Iron Core Of Rotating Electric Machines (AREA)
Liquid Crystal Substances (AREA)

ZA986904A 1997-08-01 1998-07-31 Process ZA986904B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9716161.6A GB9716161D0 (en)	1997-08-01	1997-08-01	Process

Publications (1)

Publication Number	Publication Date
ZA986904B true ZA986904B (en)	1999-02-01

Family

ID=10816746

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA986904A ZA986904B (en)	1997-08-01	1998-07-31	Process

Country Status (31)

Country	Link
US (2)	US6372734B1 (cs)
EP (2)	EP1589008B1 (cs)
JP (2)	JP2001512109A (cs)
KR (1)	KR20010022241A (cs)
CN (1)	CN1125058C (cs)
AT (2)	ATE444959T1 (cs)
AU (1)	AU739255B2 (cs)
BG (1)	BG64796B1 (cs)
BR (1)	BR9811061A (cs)
CA (1)	CA2295792C (cs)
CY (2)	CY2200162T2 (cs)
CZ (1)	CZ299225B6 (cs)
DE (4)	DE98936529T1 (cs)
EE (1)	EE04550B1 (cs)
ES (2)	ES2296568T3 (cs)
GB (2)	GB9716161D0 (cs)
HU (1)	HU228620B1 (cs)
ID (1)	ID24219A (cs)
IL (1)	IL133618A (cs)
MY (1)	MY120999A (cs)
NO (1)	NO20000484L (cs)
NZ (1)	NZ501914A (cs)
PL (1)	PL338384A1 (cs)
PT (2)	PT1000043E (cs)
RU (1)	RU2224754C2 (cs)
SI (2)	SI1000043T1 (cs)
SK (1)	SK287145B6 (cs)
TR (1)	TR200000848T2 (cs)
TW (1)	TW533207B (cs)
WO (1)	WO1999006381A1 (cs)
ZA (1)	ZA986904B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4414237B2 (ja) *	2002-03-20	2010-02-10	テバファーマシューティカルインダストリーズリミティド	ケチアピンヘミフマレートの結晶形
WO2004076431A1 (en) *	2003-02-22	2004-09-10	Teva Pharmaceutical Industries Ltd.	Synthesis of quetiapine and pharmaceutically acceptable salts thereof
AU2003216705A1 (en) *	2003-03-03	2004-09-28	Hetero Drugs Limited	Novel polymorphs of quetiapine fumarate
WO2004089957A1 (en)	2003-04-07	2004-10-21	Hetero Drugs Limited	A novel crystalline form of dorzolamide hydrochloride
ES2223294B2 (es)	2003-08-08	2005-10-01	Vita Cientifica, S.L.	Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) *	2004-09-13	2006-04-20	Gabbey Lawrence W	Oil cooler with integral filter
WO2006035293A1 (en) *	2004-09-27	2006-04-06	Ranbaxy Laboratories Limited	Polymorphic forms of quetiapine hemifumarate
GB0425729D0 (en) *	2004-11-23	2004-12-22	Pliva Res & Dev Ltd	Heterocyclic compounds
WO2006056772A2 (en) *	2004-11-23	2006-06-01	Pliva Hrvatska D.O.O.	Salts of quetiapine
ES2234447B1 (es) *	2005-03-07	2006-03-01	Union Quimico-Farmaceutica S.A.	Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
JP2008502707A (ja)	2005-04-14	2008-01-31	テバファーマシューティカルインダストリーズリミティド	クエチアピンフマレートの調製方法
US20070072840A1 (en) *	2005-05-30	2007-03-29	Pandya Bhargav	Polymorphic forms of quetiapine
US8044038B2 (en) *	2005-09-30	2011-10-25	Fermion Oy	Crystallization process of quetiapine hemifumarate
WO2007048870A1 (en) *	2005-10-28	2007-05-03	Fermion Oy	Quetiapine hemifumarate purification by crystallization
EP1951257A4 (en) *	2005-11-18	2008-11-05	Astrazeneca Ab	CRYSTALLINE FORMS
US8389510B2 (en) *	2005-11-18	2013-03-05	Astrazeneca Ab	Crystalline forms
JP2009516708A (ja) *	2005-11-18	2009-04-23	アストラゼネカ・アクチエボラーグ	液体製剤
WO2007062338A2 (en) *	2005-11-18	2007-05-31	Astrazeneca Ab	Solid formulations
EP1951694A4 (en) *	2005-11-18	2010-09-22	Astrazeneca Ab	FORMS OF SALTS
CZ300451B6 (cs) *	2006-07-03	2009-05-20	Farmak, A. S.	Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (en) *	2006-10-20	2008-06-05	Concert Pharmaceuticals Inc.	Dibenzothiazepine derivatives
EP1958617B1 (en)	2007-02-14	2010-09-08	Laboratorios Lesvi, S.L.	Pharmaceutical compositions containing quetiapine fumarate
US20080241949A1 (en) *	2007-03-29	2008-10-02	Vinod Kumar Kansal	Process for preparing quetiapine fumarate
WO2009004480A2 (en) *	2007-05-07	2009-01-08	Actavis Group Ptc Ehf	Quetiapine salts and their polymorphs
US20090082334A1 (en) *	2007-09-25	2009-03-26	Protia, Llc	Deuterium-enriched quetiapine
US8461145B2 (en) *	2007-12-05	2013-06-11	Janssen Pharmaceutica Nv	Dibenzoazepine and dibenzooxazepine TRPA1 agonists
DE202009018024U1 (de)	2008-08-01	2010-12-09	Krka Tovarna Zdravil, D.D., Novo Mesto	Quetiapin-Zusammensetzung
WO2010033270A1 (en) *	2008-09-17	2010-03-25	Auspex Pharmaceuticals, Inc.	Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
WO2010100623A1 (en)	2009-03-04	2010-09-10	Ranbaxy Laboratories Limited	Process for the preparation of quetiapine fumarate
JP6096774B2 (ja)	2011-08-12	2017-03-15	キアゲンゲゼルシャフトミットベシュレンクテルハフツング	核酸を単離するための方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE787249A (fr)	1971-08-05	1973-02-05	Squibb & Sons Inc	Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) *	1986-03-27	1986-04-30	Ici America Inc	Thiazepine compounds
GB8705574D0 (en) *	1987-03-10	1987-04-15	Ici Plc	Preparation of thiazepine compound

1997
- 1997-08-01 GB GBGB9716161.6A patent/GB9716161D0/en active Pending
1998
- 1998-07-10 GB GBGB9814882.8A patent/GB9814882D0/en active Pending
- 1998-07-28 DE DE98936529T patent/DE98936529T1/de active Pending
- 1998-07-28 PT PT98936529T patent/PT1000043E/pt unknown
- 1998-07-28 AT AT98936529T patent/ATE444959T1/de active
- 1998-07-28 CA CA002295792A patent/CA2295792C/en not_active Expired - Fee Related
- 1998-07-28 EE EEP200000062A patent/EE04550B1/xx not_active IP Right Cessation
- 1998-07-28 AU AU85498/98A patent/AU739255B2/en not_active Ceased
- 1998-07-28 SI SI9830923T patent/SI1000043T1/sl unknown
- 1998-07-28 DE DE69841216T patent/DE69841216D1/de not_active Expired - Lifetime
- 1998-07-28 NZ NZ501914A patent/NZ501914A/en not_active IP Right Cessation
- 1998-07-28 ID IDW20000029A patent/ID24219A/id unknown
- 1998-07-28 KR KR1020007000814A patent/KR20010022241A/ko not_active Ceased
- 1998-07-28 EP EP05011169A patent/EP1589008B1/en not_active Expired - Lifetime
- 1998-07-28 JP JP2000505140A patent/JP2001512109A/ja active Pending
- 1998-07-28 CZ CZ20000341A patent/CZ299225B6/cs not_active IP Right Cessation
- 1998-07-28 PT PT05011169T patent/PT1589008E/pt unknown
- 1998-07-28 IL IL13361898A patent/IL133618A/en not_active IP Right Cessation
- 1998-07-28 SI SI9830929T patent/SI1589008T1/sl unknown
- 1998-07-28 BR BR9811061-6A patent/BR9811061A/pt not_active Application Discontinuation
- 1998-07-28 DE DE69842104T patent/DE69842104D1/de not_active Expired - Lifetime
- 1998-07-28 CN CN98807572A patent/CN1125058C/zh not_active Expired - Fee Related
- 1998-07-28 PL PL98338384A patent/PL338384A1/xx not_active Application Discontinuation
- 1998-07-28 RU RU2000105271/04A patent/RU2224754C2/ru not_active IP Right Cessation
- 1998-07-28 ES ES05011169T patent/ES2296568T3/es not_active Expired - Lifetime
- 1998-07-28 SK SK130-2000A patent/SK287145B6/sk not_active IP Right Cessation
- 1998-07-28 TR TR2000/00848T patent/TR200000848T2/xx unknown
- 1998-07-28 AT AT05011169T patent/ATE496037T1/de active
- 1998-07-28 HU HU0002663A patent/HU228620B1/hu not_active IP Right Cessation
- 1998-07-28 EP EP98936529A patent/EP1000043B1/en not_active Expired - Lifetime
- 1998-07-28 DE DE05011169T patent/DE05011169T1/de active Pending
- 1998-07-28 US US09/463,452 patent/US6372734B1/en not_active Expired - Lifetime
- 1998-07-28 WO PCT/GB1998/002260 patent/WO1999006381A1/en not_active Ceased
- 1998-07-28 TW TW087112313A patent/TW533207B/zh not_active IP Right Cessation
- 1998-07-28 ES ES98936529T patent/ES2296575T3/es not_active Expired - Lifetime
- 1998-07-29 MY MYPI98003471A patent/MY120999A/en unknown
- 1998-07-31 ZA ZA986904A patent/ZA986904B/xx unknown
2000
- 2000-01-31 NO NO20000484A patent/NO20000484L/no unknown
- 2000-02-22 BG BG104176A patent/BG64796B1/bg unknown
2002
- 2002-03-21 US US10/101,948 patent/US20020147186A1/en not_active Abandoned
2008
- 2008-03-04 CY CY20082200005T patent/CY2200162T2/el unknown
- 2008-03-04 CY CY20082200004T patent/CY2200161T2/el unknown
- 2008-12-09 JP JP2008313248A patent/JP2009102345A/ja active Pending

Also Published As

Publication number	Publication date
IL133618A (en)	2004-02-08
IL133618A0 (en)	2001-04-30
BG104176A (en)	2000-08-31
TW533207B (en)	2003-05-21
WO1999006381A1 (en)	1999-02-11
RU2224754C2 (ru)	2004-02-27
BG64796B1 (bg)	2006-04-28
GB9814882D0 (en)	1998-09-09
PT1000043E (pt)	2009-11-30
PL338384A1 (en)	2000-10-23
CY2200162T2 (el)	2010-07-28
TR200000848T2 (tr)	2000-08-21
HUP0002663A3 (en)	2001-10-29
DE69841216D1 (de)	2009-11-19
EP1000043B1 (en)	2009-10-07
EP1589008B1 (en)	2011-01-19
DE69842104D1 (de)	2011-03-03
SK287145B6 (sk)	2010-01-07
SI1589008T1 (sl)	2011-04-29
US20020147186A1 (en)	2002-10-10
GB9716161D0 (en)	1997-10-08
NO20000484L (no)	2000-03-16
CY2200161T2 (el)	2010-07-28
CZ299225B6 (cs)	2008-05-21
HUP0002663A2 (hu)	2001-09-28
ES2296568T3 (es)	2011-05-06
NZ501914A (en)	2001-09-28
ES2296575T3 (es)	2010-02-05
EP1000043A1 (en)	2000-05-17
SI1000043T1 (sl)	2010-01-29
JP2001512109A (ja)	2001-08-21
HK1029992A1 (en)	2001-04-20
CN1265101A (zh)	2000-08-30
HK1081962A1 (en)	2006-05-26
CA2295792C (en)	2007-04-17
CA2295792A1 (en)	1999-02-11
US6372734B1 (en)	2002-04-16
ES2296575T1 (es)	2008-05-01
CZ2000341A3 (cs)	2000-05-17
ATE496037T1 (de)	2011-02-15
EE04550B1 (et)	2005-10-17
ES2296568T1 (es)	2008-05-01
AU739255B2 (en)	2001-10-04
AU8549898A (en)	1999-02-22
KR20010022241A (ko)	2001-03-15
MY120999A (en)	2005-12-30
CN1125058C (zh)	2003-10-22
DE98936529T1 (de)	2008-11-20
EP1589008A1 (en)	2005-10-26
JP2009102345A (ja)	2009-05-14
ATE444959T1 (de)	2009-10-15
SK1302000A3 (en)	2000-06-12
EE200000062A (et)	2000-10-16
ID24219A (id)	2000-07-13
PT1589008E (pt)	2011-03-23
NO20000484D0 (no)	2000-01-31
BR9811061A (pt)	2000-09-19
DE05011169T1 (de)	2008-11-06
HU228620B1 (en)	2013-04-29

Publication	Publication Date	Title
GB9716161D0 (en)	1997-10-08	Process
AU681198B2 (en)	1997-08-21	Preparation of 3,4,4-trisubstituted-piperidinyl-N- alkylcarboxylates and intermediates
NZ333586A (en)	2000-05-26	Anticonvulsant sulfamate derivatives, preferably topiramate, useful in treating obesity
BG106786A (en)	2003-05-30	Process for the preparation of amorphous atorvastatin
HUP9800465A3 (en)	2001-04-28	A polymer-fibre prepreg, a method for the preparation thereof as well as the use of said prepreg
AU3548993A (en)	1993-09-30	Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
AU3696197A (en)	1998-02-10	Process for the recovery of crystalline beta-carotene from natural source
EP0484769A3 (en)	1992-11-04	Improved process for crystallizing l-alpha-aspartyl-l-phenylalanine methyl ester from the solution
AU5935494A (en)	1994-11-24	Process for producing methyl formate
GB2327420B (en)	1999-06-09	Process for the production of oxygenated compounds
DE69411387D1 (de)	1998-08-06	Verfahren zur Herstellung von pharmazeutisch aktiven Benzothiazepinderivaten.
HU9904315D0 (en)	2000-01-28	Process for preparing orthoesters
AU638258B2 (en)	1993-06-24	Photoimaging process using water removable coatings
AU8453691A (en)	1992-04-30	A process for treating animal hairs by means of solubilization
IL97672A0 (en)	1992-06-21	Process for producing d-isocitric acid by fermentation
HUP9800614A3 (en)	1999-04-28	Process for producing 1,3-dioxane compounds
CS563790A3 (en)	1992-06-17	Process for preparing dichloropropanol solution
IE891895L (en)	1989-12-14	2-amino-7-hydroxytetraline ethers
EP0672755A3 (en)	1997-03-26	Fermentation process for the production of phenylacetic acid from phenylalanine.
GR1003358B (el)	2000-04-10	Διαδικασια παραγωγης 1,2-διμεθυλ-3-υδροξυπυριδ-4-ονης
ZA974928B (en)	1997-12-18	Process for the preparation of organic salts of N'N-Diacetylcystine.
CA2174506A1 (en)	1995-05-04	Process for Preparing 3,4-Diaryl-5-Isoxazolyl Acetic Acid Derivatives
AU2381595A (en)	1996-10-30	Process for desalinating water while producing power
HU906336D0 (en)	1991-04-29	Process for producing biocide preparatives
CS659990A3 (en)	1992-07-15	Process for preparing crystalline 3,4-dimethyl-phenyl-n-d-ribitylamine